Exper Perspectives Logo
  • Home
  • Therapeutic Categories
    • BACK
    • Therapeutic Categories
    • Allergy & Immunology
      • BACK
      • Allergy & Immunology
      • Chronic Spontaneous Urticaria
      • Food Allergies
      • Pediatric Food Allergies
    • Dermatology
      • BACK
      • Dermatology
      • Atopic Dermatitis
      • Plaque Psoriasis
    • Endocrinology
      • BACK
      • Endocrinology
      • Type 2 Diabetes
    • Gastroenterology
      • BACK
      • Gastroenterology
      • Crohn's Disease
      • Ulcerative Colitis
    • Hematology
      • BACK
      • Hematology
      • Chronic Immune Thrombocytopenia
      • Paroxysmal Nocturnal Hemoglobinuria
      • Sickle Cell Disease
    • Hepatology
      • BACK
      • Hepatology
      • Liver Fibrosis
    • Infectious Diseases
      • BACK
      • Infectious Diseases
      • Adolescent Vaccinations
      • COVID-19 Prevention
      • Influenza
    • Nephrology
      • BACK
      • Nephrology
      • IgAN
      • IgAN & C3G
      • Renal Transplant Maintenance
    • Neurology
      • BACK
      • Neurology
      • Alzheimer's Disease
      • Epilepsy
      • Generalized Myasthenia Gravis
      • Insomnia
      • Migraine
      • Multiple Sclerosis
      • Relapsing Multiple Sclerosis
      • Spinal Muscular Atrophy
      • Tuberous Sclerosis Complex
    • Oncology
      • BACK
      • Oncology
      • Acute Myeloid Leukemia
      • Advanced Prostate Cancer
      • Advanced ROS1-positive NSCLC
      • Anemia in MDS
      • Carcinoid Syndrome
      • Chronic Graft-versus-Host Disease
      • Chronic Lymphocytic Leukemia
      • Chronic Myeloid Leukemia
      • Endometrial Cancer
      • Gastroenteropancreatic Neuroendocrine Tumors
      • Gastrointestinal Stromal Tumors
      • HER2+ Breast Cancer
      • HR+ HER2- Breast Cancer
      • HR+ HER2- Early Breast Cancer
      • Locally Advanced Basal Cell Carcinoma
      • Mantle Cell Lymphoma
      • Melanoma
      • Metastatic Breast Cancer
      • Metastatic Pancreatic Cancer
      • Multiple Myeloma
      • Myelofibrosis
      • Myeloproliferative Neoplasms
      • Non-Small Cell Lung Cancer
      • Prostate Cancer
      • PSMA+ mCRPC
      • Relapsed/Refractory Diffuse Large B-Cell Lymphoma
      • Relapsed/Refractory Multiple Myeloma
    • Ophthalmology
      • BACK
      • Ophthalmology
      • Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
      • Wet AMD
    • Osteoporosis
      • BACK
      • Osteoporosis
      • Osteoporosis
    • Psychiatry
      • BACK
      • Psychiatry
      • Major Depressive Disorder
      • Schizophrenia
      • Tardive Dyskinesia
    • Pulmonology
      • BACK
      • Pulmonology
      • Asthma
      • COPD
      • Interstitial Lung Disease
    • Rheumatology
      • BACK
      • Rheumatology
      • Psoriatic Arthritis
      • Rheumatoid Arthritis
      • Systemic Lupus Erythematosus
    • Urology
      • BACK
      • Urology
      • Uncomplicated Urinary Tract Infections
  • Conference Reporter
  • Expert Directory
  • About Expert Perspectives
  • Login/Register

experspadmin

Can Research on Drug-Induced Lupus Erythematosus Shed Light on Autoimmunity?
Rheumatology

Can Research on Drug-Induced Lupus Erythematosus Shed Light on Autoimmunity?

clinical topic updates
By George C. Tsokos, MD
Genetic Susceptibility to Common and Severe Manifestations of Systemic Lupus Erythematosus
Rheumatology

Genetic Susceptibility to Common and Severe Manifestations of Systemic Lupus Erythematosus

clinical topic updates
By Joan T. Merrill, MD
Systemic Lupus Erythematosus: Outcomes With B-Cell Inhibition in the Real-World Setting
Rheumatology

Systemic Lupus Erythematosus: Outcomes With B-Cell Inhibition in the Real-World Setting

patient care perspectives
By Bevra H. Hahn, MD
Therapeutic Developments in Systemic Lupus Erythematosus: Treatment and Maintenance
Rheumatology

Therapeutic Developments in Systemic Lupus Erythematosus: Treatment and Maintenance

patient care perspectives
By Joan T. Merrill, MD
The Treatment Target in Newly Diagnosed Systemic Lupus Erythematosus: Preventing Early Damage
Rheumatology

The Treatment Target in Newly Diagnosed Systemic Lupus Erythematosus: Preventing Early Damage

expert roundtables
By Bevra H. Hahn, MD; George C. Tsokos, MD; Joan T. Merrill, MD
Load More   
logo 2026 Expert Perspectives®
Privacy Policy     Terms of Service     About Expert Perspectives

Your California Privacy Rights     Do Not Sell My Personal Information
Login Expert Perspectives
Forgot Password?
or Create an Account
Create an Account
Forgot Password?